Current Issue - May 2009, Volume 3, Issue No. 1

1. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for medical management of osteoarthritis. Pt II. Osteoarthritis of knee. Arthritis Rheum. 1995; 38(11): 1541-6.
2. Hart LE. Long-term effect of glucosamine sulfate on progression of knee osteoarthritis. Clin J Sport Med. 2002; 12(2): 134-5.
3. Altman RD, Moskowitz RW, and Schnitzer TJ. Recommendation for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000; 43(9): 1905-15.
4. Khanuja HS Hungerford MW, and Manjoo A. Intraarticular injections for the treatment of osteoarthritis of the knee: basic science, results and indications. Curr Opin Orthop. 2003;14: 62-68.
5. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum. 1986; 29(8): 1039-49.
6. Altman RD, Fries JF, Bloch DA. Radiographic assessment of progression of osteoarthritis. Arthritis Rheum. 1987; 31: 1214-25.
7. Felson DT, Anderson JJ, Naimark A. Obesity and knee osteoarthritis. The Framington study. Ann Intern Med. 1988; 109: 18-24.
8. Davis MA, Ettinger WH, Neuhans JM. The association of knee injury and obesity with unilateral and bilateral osteoarthritis of the knee. Am J Epidemiol. 1989; 130: 278-8.
9. Lequesne MG: The algofunctional indices for hip and knee osteoarthritis. J. Rheumatol 1997; 24: 779-81.

Abstract   |   Reference